Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × pomalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 41 Recurrence 10 Neoplasms, Plasma Cell 6 Primary Myelofibrosis 3 Waldenstrom Macroglobulinemia 2 Polycythemia Vera 2 Myeloproliferative Disorders 2 Thrombocythemia, Essential 1 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Sarcoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Small Cell 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡